Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Temsirolimus & Renal cell carcinoma (RCC), The US FDA approved temsirolimus on May 30, 2007, for the treatment of advanced renal cell carcinoma as a single‑agent therapy (1).
The European Commission authorized temsirolimus on November 19, 2007, for the first‑line treatment of patients with advanced renal cell carcinoma who have at least three of six prognostic risk factors (including poor‑risk, previously untreated patients) (1).
A…